RECRUITINGOBSERVATIONAL
Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory Diseases
Armenian Nationwide Registry of Systemic Autoimmune and Autoinflammatory Diseases
About This Trial
Longitudinal prospective multicenter Armenian registry of systemic autoimmune, autoinflammatory diseases with constitution of bio-banking.
Who May Be Eligible (Plain English)
Who May Qualify:
1. Patients with a confirmed diagnosis of at least one of following autoimmune systemic diseases:
Behcet disease, ANCA -positive vasculitis, Takayasu arteritis, Giant cell arteritis, Systemic sclerosis, Sjogren syndrome, Rheumatoid arthritis, Spondylarthritis (psoriatic, ankylosing, crohn's related), Angioedema hereditary and acquired, Pediatric dermatology, Autoinflammatory diseases (hereditary and acquired), Unexplained infertility, Immune thrombocytopenic purpura/ Autoimmune hemolytic anemia (ITP, AHA), Primary anti-phospholipid syndrome (APS), Celiac disease.
2. Age: major and minor
3. Patients who have been informed and provided with written willing to sign a consent form to participate Or consent from legal representative
Who Should NOT Join This Trial:
1. Patients refusing to participate in the registry
2. Non-consent from legal representative
3. Breastfeeding or pregnant patients
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
1. Patients with a confirmed diagnosis of at least one of following autoimmune systemic diseases:
Behcet disease, ANCA -positive vasculitis, Takayasu arteritis, Giant cell arteritis, Systemic sclerosis, Sjogren syndrome, Rheumatoid arthritis, Spondylarthritis (psoriatic, ankylosing, crohn's related), Angioedema hereditary and acquired, Pediatric dermatology, Autoinflammatory diseases (hereditary and acquired), Unexplained infertility, Immune thrombocytopenic purpura/ Autoimmune hemolytic anemia (ITP, AHA), Primary anti-phospholipid syndrome (APS), Celiac disease.
2. Age: major and minor
3. Patients who have been informed and provided with written informed consent to participate Or consent from legal representative
Exclusion Criteria:
1. Patients refusing to participate in the registry
2. Non-consent from legal representative
3. Breastfeeding or pregnant patients
Treatments Being Tested
OTHER
Usual medical management of patients, additional blood and stool samples for biobanking
For all systemic diseases the following data will be collected: Clinical examination, Laboratory data, Current medications, Constitution of biobanking. For each disease: Pathology specific Activity score, Global subjective disease activity by patient and by physician.
Locations (6)
Hematology Center after Prof.R.H. Yeolyan
Yerevan, Armenia
Nairi Medical Center, Rheumatology Department
Yerevan, Armenia
Heratsi Hospital Complex n°1, Rheumatology Department
Yerevan, Armenia
Heratsi Hospital Complex №1, Allergology Department
Yerevan, Armenia
Mikaelyan Institute of Surgery, Rheumatology Department
Yerevan, Armenia
Erebouni Medical Center, Rheumatology Department
Yerevan, Armenia